Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CRMD has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
CRMD stock price ended at $12.75 on Monday, after rising3.83%
The CorMedix Inc stock price increased by 3.83% on the last trading day (19 May 2025), rising from 12.2083 to 12.75. Throughout the last trading session, the stock experienced a fluctuation of 5.71% , ranging from a day low of $12.175 to a day high of 12.87. The price has declined in 3 of the last 10 days, resulting in a total change of 41.20% during this period. On the last day, trading volume decrease by -114.64K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 1.31M shares were traded, amounting to approximately 16.43M.
CRMD Technical Signals
CRMD(CorMedix Inc Corp) has 4 buy signals and 5 sell signals now. The current trend is consolidation starting from 2025-05-15. The total price change during this trend is +9.07%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of CRMD over the last 5 trading days is 13.47M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
CRMD Moving Average Analysis
CorMedix Inc's overall moving average trend leans more bullish as of Tuesday, May 20, 2025, with 0 negative signals and 4 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $13.488929999999998, and $14.781999999999998. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $9.305069999999999, and $8.011999999999999. A break-down below any of these levels will issue sell signals.
CRMD Short Selling Analysis
The short sale ratio of CorMedix Inc(CRMD) as of 16 May 2025 is 15.47%, rising from last trading day. With increasing price from 11.69 to 12.28. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Neutral
Sell
5
Buy
4
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
3.047
Bullish
Momentum (10 days)
MOM_10 > 0
3.72
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
1.053
Bullish
Closing price
close > fibonacci_R1
12.75
Bullish
5 Bearish Signals
5 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Relative Strength Index (14 days)
RSI_14 > 70
76.056
Bearish
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 > 80
92.818
Bearish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
110.184
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
82.072
Bearish
Williams %R (14 days)
WILLR_14 > -20
-2.892
Bearish
CRMD Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to CorMedix Inc(CRMD), our algorithm predicts CRMD's 1-month price at $12.08, with an -1.62%downwardshift. Using a similarity score up to 99.21%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for CorMedix Inc (CRMD.O) stock, as of Sunday, May 18, 2025 , forecasts a -1.62% change over the next month, based on its high correlation with LBRDA.O stock patterns. The similarity between their price movements over the analyzed periods is 99.21%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
CRMD
Future prediction
Up: -1.62%
LBRDA
Down: -1.62%Similarity: 99.21%
Name
Similarity
Up/Down
LBRDA.O
99.21%
-1.62%
IGT.N
99.11%
-0.57%
PGR.N
99.07%
+7.59%
MTNB.A
99.06%
+34.46%
ALX.N
99.03%
-0.97%
ITGR.N
98.93%
-6.11%
MAN.N
98.93%
+9.08%
CRWD.O
98.90%
+14.20%
LDOS.N
98.85%
+8.60%
GOOGL.O
98.80%
-2.47%
CRMD Seasonality Analysis
Based on CRMD's historical stock price data across all years, the probability of a positive return in May is27.27%, suggesting it maynotbe an ideal month to invest in CRMD. In contrast,Augustoffers the highest probability of positive returns at60.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying CorMedix Inc (CRMD.O) stock in August has the highest probability of a positive return (60.00%), while May has the lowest probability (27.27%).
Performance Seasonality
The chart shows CorMedix Inc. (CRMD)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CRMD has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying CorMedix Inc (CRMD.O) stock in a year?
The radar chart shows that buying CorMedix Inc (CRMD.O) stock in August has the highest probability of a positive return (60.00%), while May has the lowest probability (27.27%).
How has CorMedix Inc. (CRMD)'s stock price performed over the past three years?
CRMD's stock price fell by -10.05% in 2023,increased by 114.85% in 2024, and went up by 55.11% in 2025.
Which bull technical signals does CRMD have?
Bullish technical signals of CRMD include: AO_5_34 > 0, MOM_10 > 0, MACD_12_26_9 > 0, close > fibonacci_R1.
Is CRMD a buy based on overall technical signals summary?
CRMD has 4 buy signals and 5 sell signals now. Overall the technical rating for CRMD is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of CRMD.
What is the trend of CorMedix Inc (CRMD)'s moving average?
CorMedix Inc's overall moving average trend leans more bullish as of May 20 2025, with 0 negative signals and 4 positive signal.
What is price prediction for CRMD stock next month?
The price prediction chart for CorMedix Inc (CRMD.O) stock, as of May 18 2025, forecasts a -1.62% change over the next month, based on its high correlation with LBRDA stock patterns. The similarity between their price movements over the analyzed periods is 99.21%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for CRMD Stock?
CRMD stock is predicted to reach a price range of **$14 to $16** by the end of 2025, driven by strong Q1 2025 earnings beating estimates and increased H1 2025 net sales guidance. The stock's technical indicators, such as RSI and MACD, suggest continued upward momentum.
What is price prediction 2030 for CRMD Stock?
CRMD stock is predicted to reach **$25 by 2030**, driven by strong revenue growth from DefenCath and expanding market share. The company's recent financial outperformance and positive analyst sentiment support this bullish outlook.